Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials
Andrew Blauvelt, Kristian Reich, Mark Lebwohl, Daniel Burge, Catherine Arendt, Luke Peterson, Robert Rolleri, Alice Gottlieb
Abstract not available.
Disclosures: Study sponsored by UCB Pharma.
Copyright 2018 SKIN
certolizumab; psoriasis; clinical trial
Abstract - 159 Poster PDF - 58
- There are currently no refbacks.